Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Landec Corporation

Landec Corporation (LNDC) Stock Overview

Explore Landec Corporation’s financial performance, market position, analyst ratings, and future outlook.

LNDC●NASDAQ
HealthcareDrug Manufacturers - Specialty & Generic
$8.76
$0.32(3.52%)
U.S. Market is Open · 13:57

Landec Corporation (LNDC)

Meyka AI Score

Z

Key Financials

Market Cap263.6M
P/E Ratio-8.19
EPS (TTM)$-2.17
ROE6.44%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year TargetN/A

LNDC Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Landec Corporation (NASDAQ: LNDC) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Landec Corporation's NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of LNDC on the NASDAQ shows an RSI of N/A, suggesting the stock is in a an undetermined condition. Our forecasting models predict a 12-month price target of $N/A for the NASDAQ listing.

Key metrics behind Landec Corporation's NASDAQ-traded stock include a P/E ratio of -8.19 and a market capitalization of 263.6M. Combined with our AI analysis, these give both institutional and retail investors a clear view of LNDC on the NASDAQ.

Price Performance (NASDAQ: LNDC)

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
22.69%
3-Month Change
-3.52%
6-Month Change
-21.99%
Year-to-Date (YTD) Change
N/A
1-Year Change
-23.96%
3-Year Change
-22.68%
5-Year Change
-33.38%
All-Time (Max) Change
-31.29%

Contact Information

https://www.landec.com
16503061650
5201 Great America Pkwy Ste 232, Santa Clara, CA, 93455

Company Facts

6,890 Employees
IPO DateFeb 16, 1996
CountryUS

Frequently Asked Questions